Clinical Trial: International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420855) titled 'International Multicentric Retrospective Study on the Use of EV+P as First-line Therapy in Patients With la/mUC' on Dec. 11, 2025.

Brief Summary: The ARON-2PLUS Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of Enfortumab vedotin plus Pembrolizumab as first-line therapy in patients with locally advanced/metastatic Urothelial Cancer.

Two supplementary optional studies are designed: one is related to CT scans evaluation for 3D reconstruction analysis; the other one is an omic analysis on FFPE tissue.

Study Start Date: Feb., 2026

Study Type: OBSERVATIONAL

Condition:...